PE Fund Investments
Contract manufacturer Biodeal Pharma raises Rs.110-Cr from Piramal Alternatives
Piramal Alternatives is investing INR 110 crore in Noida-headquartered Biodeal Pharmaceuticals Ltd , a contract development and manufacturing company. The funds would be used to improve infrastructure and capacities, upgrade technology, and set up a dedicated nutraceuticals manufacturing facility.Biodeal’s product basket includes dosage formats, including dry powder inhalation capsules, capsules, tablets, ointments, lotions, and dusting powder.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
